Nomura Securities Raises Price Target on Rollins (ROL) to $32
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Nomura Securities reiterated a Buy rating on Rollins (NYSE: ROL), and raised the price target to $32.00 (from $30.00), after meeting with management.
Analyst Dan Dolev commented, "We recently spent a day in Tokyo in meetings with ROL’s CFO Eddie Northen. Since bugs have been in existence since nearly the dawn of time, we expected to hear little new news. This was indeed the case, as key features like ROL’s signature 80% recurring revenue, up to 90% customer retention rates, rare price inelasticity and 14 consecutive years of 12%+ dividend growth took center stage."
Shares of Rollins closed at $29.19 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- M&T Bank (MTB) PT Raised to $165 at FBR Capital Following 4Q Beat
- Instinet (Nomura) Downgrades Silicon Motion Technology (SIMO) to Neutral
- Drexel Hamilton Reiterates Buy on IBM (IBM) Following 4Q Report
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!